Literature DB >> 21167240

The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs).

E Fiedorowicz1, B Jarmołowska, M Iwan, E Kostyra, R Obuchowicz, M Obuchowicz.   

Abstract

Milk is one of the main source of biologically-active peptides that may function as regulatory substances called food hormones. After passing the gut-blood barrier, the μ-opioid receptor agonist and antagonist peptides may become the new factors influencing various functions of the human organism. The aim of the conducted research was to determine the influence of μ-opioid receptor agonist peptides: human and bovine β-casomorphin-7 (h/bBCM-7) and antagonistic peptides: casoxin-6 and- D (CXN-6/D) on proliferation and cytokine secretion of human peripheral blood mononuclear cells (PBMCs). The PBMCs proliferation was measured by the use of the BrdU test, which assesses the DNA synthesis activity and the WST-1 test which assesses the activity of mitochondrial dehydrogenase enzymes. The influence of all the investigated peptides on secretion of IL-4, IL-8, IL-13 and IFN-γ was determined by the use of the ELISA tests. Incubating the cells with the peptides has not caused any changes to their enzymatic activity, which has been proved by a WST-1 test. When using a BrdU test, however, it has been observed that there appear changes to proliferation of PBMCs correlated to amounts of bromodeoxyuridine incorporated into the cellular DNA. Moreover, changes to secretion of IL-4 and IL-13 by the cells under the influence of agonists were detected, as well as changes to secretion of IFN-gamma under the influence of all the examined substances. The obtained results provide information on immunomodulatory effects of food-derived opioid peptides, which may be of clinical significance especially in the case of allergic diseases in newborns.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167240     DOI: 10.1016/j.peptides.2010.12.003

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Comparative evaluation of cow β-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut.

Authors:  Mohammad Raies Ul Haq; Rajeev Kapila; Rohit Sharma; Vamshi Saliganti; Suman Kapila
Journal:  Eur J Nutr       Date:  2013-10-29       Impact factor: 5.614

2.  The milk-derived fusion peptide, ACFP, suppresses the growth of primary human ovarian cancer cells by regulating apoptotic gene expression and signaling pathways.

Authors:  Juan Zhou; Mengjing Zhao; Yigui Tang; Jing Wang; Cai Wei; Fang Gu; Ting Lei; Zhiwu Chen; Yide Qin
Journal:  BMC Cancer       Date:  2016-03-24       Impact factor: 4.430

3.  Milk‑derived hexapeptide PGPIPN prevents and attenuates acute alcoholic liver injury in mice by reducing endoplasmic reticulum stress.

Authors:  Qia Xu; Hao Xi; Xi Chen; Yin Xu; Peng Wang; Jingwen Li; Wenmei Wei; Fang Gu; Yide Qin
Journal:  Int J Mol Med       Date:  2020-06-16       Impact factor: 4.101

4.  PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2.

Authors:  Wei Wang; Fang Gu; Cai Wei; Yigui Tang; Xin Zheng; Mingqiang Ren; Yide Qin
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

5.  Inflammation in low back pain may be detected from the peripheral blood: suggestions for biomarker.

Authors:  Yong Li; Jun Liu; Zong-Zhi Liu; Da-Peng Duan
Journal:  Biosci Rep       Date:  2016-08-05       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.